Companies: 10,795·Total market cap: $144.5T
argenx SE

argenx SE

ARGXNASDAQHealthcare● Active
$882.03
$-9.29(-1.04%)
Market Cap$54.6B
P/E Ratio—
52W High$934.62
52W Low$510.055
Cash on HandFinancialsRevenue

argenx SE (ARGX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ARGX · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$4.44B▲ +31.4% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$3.49B
cashAndCashEquivalents
Short-Term Investments
$948.8M
shortTermInvestments
YoY Change vs Prior Year
+31.4%
vs prior fiscal year
Latest Quarter
$4.44B
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$4.44BCash on Hand
Total Debt$83.5MTotal Debt
Net Cash / Net Debt+$4.36BNet Cash Position
Cash vs Debt Ratio
Cash 98%Debt 2%

argenx SE has a net cash position of $4.36B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$4.44B − $83.5M = +$4.36B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ARGX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$4.44B+31.4%
Dec 31, 2024$3.38B+6.3%
Dec 31, 2023$3.18B+45.0%
Dec 31, 2022$2.19B-6.2%
Dec 31, 2021$2.34B+17.0%
ARGX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
argenx SE
argenx SEYOU
ARGX
$4.44B8.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

argenx SE (ARGX) cash on hand as of December 31, 2025 is $4.44B, comprising $3.49B in cash and cash equivalents (CCE) plus $948.8M in short-term investments — reported as argenx SE cash and short-term investments on the balance sheet (10-K filing). Also referred to as argenx SE cash reserves or cash position.

argenx SE annual cash on hand history shows increased +31.4% in 2025: increased +31.4% in 2025. argenx SE cash reserves in 2025 reflect the company's capital allocation strategy.

argenx SE carries total debt of $83.5M against cash of $4.44B, resulting in a net cash position of +$4.36B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ARGX cash on hand · 5 questions

As of December 31, 2025, argenx SE (ARGX) has $4.44B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $3.49B in cash and cash equivalents (CCE) plus $948,750,000 in short-term investments. Latest quarter (December 31, 2025): $4.44B. Data sourced from the annual 10-K filing via FMP.

ARGX cash on handARGX cash reservesARGX cash 2025how much cash does ARGX have

▸ Source: FMP /balance-sheet-statement · US GAAP · argenx SE · argenx SE SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025